While a meta‐analysis by Diggikar et al. (2023) linked anti‐VEGF therapy to a higher risk of cognitive impairment compared to laser treatment, our analysis found no significant difference in neurodevelopmental impairment or cerebral palsy between treatments. This evidence concerns the gene VEGFA and cerebral palsy.